MDSCs in infectious diseases: regulation, roles, and readjustment.
Dorhoi AInstitute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Südufer 10, 17493, Greifswald, Insel Riems, Germany. anca.dorhoi@fli.de.
Glaría ENuclear Receptor Group, Department of Cell Biology, Physiology and Immunology, School of Biology, University of Barcelona, Av. Diagonal, 643, 3rd floor, 08028, Barcelona, Spain.
Garcia-Tellez TInstitut Pasteur, HIV Inflammation and Persistence Unit, Paris, France.
Nieuwenhuizen NEDepartment of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.
Zelinskyy GInstitute of Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Favier BImmunology of Viral Infections and Autoimmune Diseases (IMVA), IDMIT Department, CEA, Université Paris Sud 11, INSERM U1184, IBJF, Fontenay-aux-Roses, France.
Singh AUniversity Children's Hospital and Interdisciplinary Center for Infectious Diseases, University of Tübingen, Tübingen, Germany.
Ehrchen JDepartment of Dermatology, University Hospital Münster, Münster, Germany.
Gujer CViral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zurich, Switzerland.
Münz CViral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zurich, Switzerland.
Saraiva Mi3S-Instituto de Investigação e Inovação em Saúde, Porto, Portugal.
Sohrabi YMolecular and Translational Cardiology, Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany.
Sousa AEInstituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Delputte PLaboratory of Microbiology, Parasitology and Hygiene (LMPH), Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium.
Müller-Trutwin MInstitut Pasteur, HIV Inflammation and Persistence Unit, Paris, France.
Valledor AFNuclear Receptor Group, Department of Cell Biology, Physiology and Immunology, School of Biology, University of Barcelona, Av. Diagonal, 643, 3rd floor, 08028, Barcelona, Spain. afernandezvalledor@ub.edu.
English
Many pathogens, ranging from viruses to multicellular parasites, promote expansion of MDSCs, which are myeloid cells that exhibit immunosuppressive features. The roles of MDSCs in infection depend on the class and virulence mechanisms of the pathogen, the stage of the disease, and the pathology associated with the infection. This work compiles evidence supported by functional assays on the roles of different subsets of MDSCs in acute and chronic infections, including pathogen-associated malignancies, and discusses strategies to modulate MDSC dynamics to benefit the host.